# Equity Bancshares Inc: filings

EQBK · NYSE · CIK 1227500 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eqbk.md) · [Financials](/companies/eqbk/financials.md) · [Filings](/companies/eqbk/filings.md) · [Insiders](/companies/eqbk/insiders.md)

## Reports and events: 226 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 451, 8-K 156, 3 50, 425 46, 10-Q 33, SC 13G/A 30, CORRESP 18, SC 13G 15, EFFECT 14, 144 13, UPLOAD 13, SCHEDULE 13G/A 12, 10-K 11, DEF 14A 11, S-4 11, S-4/A 11, 4/A 10, DEFA14A 8, 424B3 7, S-8 7, D 6, ARS 4, 5 3, 8-K/A 3, S-3 3, SC 13D 3, SC 13D/A 3, 424B5 2, 8-A12B 2, D/A 2, NT 10-Q 2, PRE 14A 2, S-1/A 2, 10-K/A 1, 25 1, 3/A 1, 424B4 1, CERT 1, CERTNAS 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, NT 10-K 1, S-1 1, S-1MEF 1, S-3ASR 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 20:20 ET | [8-K](/filings/0001193125-26-421701.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-421701 |
| 2026-10-05 | 01:50 ET | [8-K](/filings/0001193125-26-412873.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-412873 |
| 2026-09-14 | 20:45 ET | [8-K](/filings/0001193125-26-390696.md) | 8.01 Other events | 0001193125-26-390696 |
| 2026-09-03 | 11:46 ET | [8-K](/filings/0001193125-26-381051.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-381051 |
| 2026-08-07 | 20:18 ET | [10-Q](/filings/0001193125-26-340292.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340292 |
| 2026-08-05 | 20:30 ET | [8-K](/filings/0001193125-26-335263.md) | 8.01 Other events | 0001193125-26-335263 |
| 2026-07-14 | 20:10 ET | [8-K](/filings/0001193125-26-303176.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-303176 |
| 2026-06-17 | 17:45 ET | [8-K](/filings/0001193125-26-273812.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-273812 |
| 2026-05-21 | 20:30 ET | [8-K](/filings/0001193125-26-234573.md) | 8.01 Other events | 0001193125-26-234573 |
| 2026-05-08 | 20:31 ET | [10-Q](/filings/0001193125-26-214751.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214751 |
| 2026-04-22 | 20:30 ET | [8-K](/filings/0001193125-26-170555.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-170555 |
| 2026-04-14 | 20:37 ET | [8-K](/filings/0001193125-26-154989.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-154989 |
| 2026-04-08 | 00:37 ET | [SCHEDULE 13D/A](/filings/0001104659-26-041077.md) | Ownership report, active investor, amended | 0001104659-26-041077 |
| 2026-03-18 | 20:55 ET | [8-K/A](/filings/0001193125-26-114201.md) | 9.01 Financial statements and exhibits | 0001193125-26-114201 |
| 2026-03-12 | 13:29 ET | [DEF 14A](/filings/0001193125-26-103215.md) | Proxy statement, period 2026-04-21 | 0001193125-26-103215 |
| 2026-03-10 | 20:23 ET | [10-K/A](/filings/0001193125-26-100184.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-100184 |
| 2026-03-06 | 21:31 ET | [10-K](/filings/0001193125-26-096665.md) | Annual report, period 2025-12-31 | 0001193125-26-096665 |
| 2026-02-23 | 21:45 ET | [8-K](/filings/0001193125-26-064190.md) | 8.01 Other events | 0001193125-26-064190 |
| 2026-02-17 | 21:45 ET | [8-K](/filings/0001193125-26-054930.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-054930 |
| 2026-01-22 | 21:45 ET | [8-K](/filings/0001193125-26-019558.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-019558 |
| 2026-01-21 | 21:30 ET | [8-K](/filings/0001193125-26-018038.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-018038 |
| 2026-01-02 | 11:00 ET | [8-K](/filings/0001193125-26-000016.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-000016 |
| 2025-12-11 | 21:45 ET | [8-K](/filings/0001193125-25-316117.md) | 8.01 Other events | 0001193125-25-316117 |
| 2025-11-05 | 21:45 ET | [8-K](/filings/0001193125-25-267125.md) | 8.01 Other events | 0001193125-25-267125 |
| 2025-11-03 | 21:46 ET | [10-Q](/filings/0001193125-25-262699.md) | Quarterly report, period 2025-09-30 | 0001193125-25-262699 |
| 2025-10-14 | 20:30 ET | [8-K](/filings/0001193125-25-239067.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-239067 |
| 2025-09-26 | 20:45 ET | [8-K](/filings/0001193125-25-220719.md) | 8.01 Other events | 0001193125-25-220719 |
| 2025-09-15 | 20:45 ET | [8-K](/filings/0001193125-25-203689.md) | 8.01 Other events | 0001193125-25-203689 |
| 2025-09-02 | 11:02 ET | [8-K](/filings/0001193125-25-193355.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-193355 |
| 2025-08-08 | 20:45 ET | [10-Q](/filings/0001193125-25-177050.md) | Quarterly report, period 2025-06-30 | 0001193125-25-177050 |
| 2025-07-18 | 13:21 ET | [8-K](/filings/0001193125-25-160898.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-160898 |
| 2025-07-14 | 20:45 ET | [8-K](/filings/0000950170-25-095610.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-095610 |
| 2025-07-10 | 15:44 ET | [SCHEDULE 13D](/filings/0001140361-25-025432.md) | Ownership report, active investor | 0001140361-25-025432 |
| 2025-07-08 | 20:15 ET | [8-K](/filings/0001193125-25-156606.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-156606 |
| 2025-07-03 | 12:45 ET | [8-K](/filings/0000950170-25-093569.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-093569 |
| 2025-06-06 | 20:35 ET | [8-K](/filings/0000950170-25-083160.md) | 8.01 Other events | 0000950170-25-083160 |
| 2025-05-22 | 20:30 ET | [8-K](/filings/0000950170-25-076376.md) | 8.01 Other events | 0000950170-25-076376 |
| 2025-05-09 | 20:30 ET | [10-Q](/filings/0000950170-25-068091.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068091 |
| 2025-05-06 | 20:46 ET | [8-K](/filings/0000950170-25-064571.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-064571 |
| 2025-04-24 | 20:50 ET | [8-K](/filings/0000950170-25-058159.md) | 5.07 Shareholder vote results | 0000950170-25-058159 |
| 2025-04-15 | 20:30 ET | [8-K](/filings/0000950170-25-054272.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-054272 |
| 2025-04-03 | 21:34 ET | [8-K](/filings/0001193125-25-071450.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-071450 |
| 2025-03-20 | 20:45 ET | [8-K](/filings/0000950170-25-042735.md) | 8.01 Other events | 0000950170-25-042735 |
| 2025-03-13 | 13:57 ET | [DEF 14A](/filings/0001193125-25-053583.md) | Proxy statement, period 2025-04-22 | 0001193125-25-053583 |
| 2025-03-07 | 21:46 ET | [10-K](/filings/0000950170-25-035585.md) | Annual report, period 2024-12-31 | 0000950170-25-035585 |
| 2025-02-11 | 21:45 ET | [8-K](/filings/0000950170-25-017986.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-25-017986 |
| 2025-02-07 | 11:03 ET | [8-K](/filings/0001193125-25-022213.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-022213 |
| 2025-01-22 | 21:45 ET | [8-K](/filings/0000950170-25-007823.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-007823 |
| 2024-12-16 | 21:45 ET | [8-K](/filings/0000950170-24-136709.md) | 8.01 Other events | 0000950170-24-136709 |
| 2024-12-03 | 14:04 ET | [8-K](/filings/0001193125-24-269479.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-269479 |

Page 1 of 5. [Older](/companies/eqbk/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.